)
bioMérieux (BIM) investor relations material
bioMérieux AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Opening remarks and agenda
The meeting opened with a review of the 2025 activity and 2026 outlook, including presentations on SpinChip, environmental commitments, auditor reports, and resolutions for shareholder voting.
Financial performance review
2025 sales reached €4,070m, up 6.2% at constant exchange rates, with strong growth in all segments except immunoassays.
Contributive EBIT rose to €728m (17.9% of sales), up 16% at constant rates, and free cash flow increased by 40% to €462m.
Net adjusted EPS grew by 9%, and a dividend of €0.98 per share (+9%) was proposed.
Investments totaled ~€330m, focused on automation and capacity expansion in the US and France.
Board and executive committee updates
Renewal of Alexandre Mérieux’s mandate as director for four years and nomination of François Lacoste as director and Jean-Luc Bélingard as censor were proposed.
The annual remuneration envelope for directors was set at €700,000.
- Q1 2026 sales fell 3.9% organically, leading to lower guidance amid market volatility.BIM
Q1 2026 TU26 Apr 2026 - 2025 sales up 6.2% to €4,070m, EBIT up 16%, with strong cash flow and robust 2026 outlook.BIM
H2 20252 Mar 2026 - Strong H1 2025 sales and margin gains offset China weakness; CEBIT guidance raised for 2025.BIM
H1 20253 Feb 2026 - Strong H1 growth and margin gains drive upgraded 2024 guidance despite FX headwinds.BIM
H1 202422 Jan 2026 - Q3 organic sales rose 11% to €969m, supporting a raised 2024 outlook amid strong growth drivers.BIM
Q3 2024 TU17 Jan 2026 - GO28 targets 7% sales growth and 20% margin by 2028, fueled by innovation and acquisitions.BIM
43rd Annual J.P. Morgan Healthcare Conference 202510 Jan 2026 - Q1 sales up 13% to €1.1B, strong BIOFIRE and SPOTFIRE growth, 2025 guidance reaffirmed.BIM
Q1 2025 TU19 Dec 2025 - Double-digit sales and profit growth in 2024, with strong outlook and innovation momentum.BIM
H2 20242 Dec 2025 - 7.3% organic sales growth YTD, with Q3 slowed by China and respiratory panel declines.BIM
Q3 2025 TU4 Nov 2025
Next bioMérieux earnings date
Next bioMérieux earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage